HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China's COVID Headwinds Slow USANA, Mannatech

Executive Summary

Both health and wellness direct sellers reported double-digit decreases in net sales and steep drops in net income for Q2.

You may also be interested in...



US Q3 Health And Wellness Results: Chromadex, Lannett, Mannatech And USANA

ChromaDex trims loss, adds Nestle as Niagen customer; currency exchange slams Mannatech; Asia-Pacific sales, currency exchange Rock USANA results; and Lannett sees upsides after 25% sales slide.

USANA Lowers Guidance After 15% Q1 Sales Drop; Mannatech Reports Nearly $1M Undelivered Goods

Due to uncertainty in COVID-19 landscape in China, USANA adjusted its 2022 fiscal year guidance. Direct seller Mannatech decreased its number of fulfilled orders by 6% in the first quarter.

USANA ‘Cautiously Optimistic’ For Sales Rebound In 30th Year Despite Disappointing End To 2021

For its 2021 FY and Q4 results, nutritional and weight loss products direct seller reports lower gross margin and marketing expenses also contributed to lower-than-expected diluted EPS, down 45% to 18 cents.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152841

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel